Security Snapshot

PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) Institutional Ownership

CUSIP: 74587V107

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

114

Shares (Excl. Options)

27.24MFull value: 27,244,120 · shares · 30 Sep 2026

Price

$9.93

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,486,222
Value change
+$16,155,228
Number of holders
114
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
51,748,170
SEC-reported price per share
$9.83
Insider filing price
$9.83
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock is tracked under CUSIP 74587V107.
  • 114 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 160 to 114 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $313.59MFull value: $313,589,160 · USD · 30 Jun 2026
    to
    $270.64MFull value: $270,638,392 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 114 institutions filings for Q3 2026.

Open SEC evidence

Security key

74587V107

13F reference period

Q3 2026

13F holders

114

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
PBYI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AUERBACH ALAN H 16% $85,885,018 8,648,958 Alan H. Auerbach 04 Oct 2026
ACORN BIOVENTURES, L.P. 8% +19% $11,859,557 +$1,988,442 3,940,052 +20% Anders Hove 31 Dec 2024
BlackRock, Inc. 5.6% $8,366,151 2,779,452 BlackRock, Inc. 31 Mar 2025
AMERICAN CENTURY INVESTMENT MANAGEMENT INC 5.3% $28,221,899 2,742,653 American Century Investment Management, Inc. 30 Sep 2026
MILLENNIUM MANAGEMENT LLC 3.9% $5,701,319 1,894,126 Millennium Management LLC 31 Dec 2024
As of 30 Sep 2026, 114 institutional investors reported holding
27.24MFull value: 27,244,120 · shares · 30 Sep 2026
shares of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI). This represents 53% of the company’s total
51.75MFull value: 51,748,170 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
38%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ACORN CAPITAL ADVISORS, LLC 8% 4,131,299 11% $41,023,799
VANGUARD PORTFOLIO MANAGEMENT LLC 3.7% 1,893,279 0% $18,800,260
RENAISSANCE TECHNOLOGIES LLC 3.6% 1,884,013 0.03% $18,708,249
VANGUARD CAPITAL MANAGEMENT LLC 3.6% 1,848,787 0% $18,358,455
DIMENSIONAL FUND ADVISORS LP 3% 1,555,733 0% $15,447,424
GEODE CAPITAL MANAGEMENT, LLC 2.6% 1,332,755 0% $13,236,849
KENNEDY CAPITAL MANAGEMENT LLC 1.8% 956,100 0.18% $9,494,073
STATE STREET CORP 1.8% 944,150 0% $9,375,410
GOLDMAN SACHS GROUP INC 1.5% 763,970 0% $7,586,222
GLOBEFLEX CAPITAL L P 1.4% 749,160 0.97% $7,439,159
Connor, Clark & Lunn Investment Management Ltd. 1.1% 583,472 0.01% $5,793,877
Empowered Funds, LLC 1% 518,809 0.02% $5,151,773
FEDERATED HERMES, INC. 0.65% 335,633 0% $3,332,836
VANGUARD FIDUCIARY TRUST CO 0.53% 274,607 0% $2,726,848
Invesco Ltd. 0.5% 256,219 0% $2,544,255
PANAGORA ASSET MANAGEMENT INC 0.42% 217,545 0.01% $2,160,222
TWO SIGMA INVESTMENTS, LP 0.42% 216,974 0% $2,154,552
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 0.37% 192,082 0% $1,907,374
WELLINGTON MANAGEMENT GROUP LLP 0.3% 155,572 0% $1,544,830
Haven Private, LLC 0.28% 146,700 0.57% $1,456,731
Prospera Financial Services Inc 0.26% 134,350 0.02% $1,402,617
Round Rock Advisors LLC 0.25% 128,912 0.17% $1,280,096
OpenArc Corporate Advisory, LLC 0.23% 119,624 0.01% $1,187,866
Integrated Quantitative Investments LLC 0.23% 119,198 0.21% $1,183,636
SummerHaven Investment Management, LLC 0.22% 114,315 0.63% $1,135,148

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 27,244,120 $270,638,392 +$16,155,228 $9.93 114
2026 Q2 38,670,173 $313,589,160 +$7,107,309 $8.11 160
2026 Q1 37,858,675 $241,840,570 +$16,254,424 $6.39 156
2025 Q4 35,345,329 $210,235,242 +$5,397,552 $5.95 151
2025 Q3 34,380,273 $182,532,985 +$11,531,913 $5.31 131
2025 Q2 32,782,327 $112,437,236 +$8,596,760 $3.43 121
2025 Q1 30,413,709 $90,020,693 +$2,952,602 $2.96 116
2024 Q4 29,394,127 $89,648,308 -$7,801,084 $3.05 111
2024 Q3 29,741,414 $75,860,432 -$5,784,759 $2.55 100
2024 Q2 30,964,332 $100,942,686 -$1,236,662 $3.26 98
2024 Q1 29,743,016 $157,668,204 +$17,052,475 $5.30 93
2023 Q4 26,608,129 $115,214,198 +$4,767,738 $4.33 82
2023 Q3 25,704,166 $67,598,924 -$2,428,856 $2.63 67
2023 Q2 26,576,438 $93,807,644 -$4,382,380 $3.53 67
2023 Q1 27,855,345 $86,065,002 -$527,663 $3.09 77
2022 Q4 27,496,427 $116,318,396 -$138,759 $4.23 86
2022 Q3 27,643,484 $65,508,451 -$1,989,453 $2.37 71
2022 Q2 27,896,143 $79,494,556 -$4,139,901 $2.85 77
2022 Q1 29,904,506 $86,071,643 -$477,483 $2.88 95
2021 Q4 30,286,741 $92,179,926 -$39,504,988 $3.04 96
2021 Q3 32,161,600 $225,498,183 -$28,665,006 $7.01 112
2021 Q2 34,758,681 $319,233,355 -$17,282,962 $9.18 118
2021 Q1 36,622,682 $355,897,814 +$13,747,740 $9.72 117
2020 Q4 35,303,327 $362,460,750 -$9,270,334 $10.26 120
2020 Q3 38,674,035 $390,198,466 +$12,930,607 $10.09 128
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .